| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-17 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 7e-07 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 4e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.19 | 0.0005 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.0006 |